1 Result for "

bivalent T cell engager therapies

" in MedChemExpress (MCE) Product Catalog:
Products (1)

1 Results for "bivalent T cell engager therapies" in MCE Product Catalog:

Cat. No.: HY-P11280A
Target:  

Melanocortin Receptor

Research Areas:  

Cancer

PRAME peptide (425-433) acetate is a proteasome-degraded peptide derived from the cancer-testis antigen PRAME (Preferentially Expressed Antigen in Melanoma). PRAME peptide (425-433) acetate is restricted by HLA-A*02:01 and can serve as a target for bispecific T cell engager therapy in the context of major histocompatibility complex I presentation. PRAME peptide (425-433) acetate shows application potential in various malignant tumors and is widely suitable for research related to solid tumors, melanoma, ovarian cancer, endometrial cancer, and lung cancer (including lung adenocarcinoma and lung squamous cell carcinoma). PRAME peptide (425-433) acetate can be used to explore disease of triple-negative breast cancer, diffuse large B-cell lymphoma, and head and neck squamous cell carcinoma .
loading...
    loading...